VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar robyjer (85.85) Submitted: 2/13/2007 12:51:32 PM : Outperform Start Price: $4.31 VVUS Score: +473.41

New drugs in pipeline, innovative direction for sexual arrousual drugs. One drug under FDA approval, if drug becomes approved, big run in price, or possible takeover target for major drug co.

Featured Broker Partners


Advertisement